Maryland 2022 Regular Session

Maryland House Bill HB970 Latest Draft

Bill / Chaptered Version Filed 06/07/2022

                             LAWRENCE J. HOGAN, JR., Governor Ch. 684 
 
– 1 – 
Chapter 684 
(House Bill 970) 
 
AN ACT concerning 
 
Managed Care Organizations and Health Insurance Carriers – Prior 
Authorization for HIV Postexposure Prophylaxis for Victims of Sexual Offenses 
– Prohibition 
 
FOR the purpose of prohibiting managed care organizations and certain insurers, nonprofit 
health service plans, and health maintenance organizations from applying a prior 
authorization requirement for prescription drugs used as postexposure prophylaxis 
for the prevention of HIV if the drug is prescribed to a victim of an alleged rape or 
sexual offense for use in accordance with Centers for Disease Control and Prevention 
guidelines; and generally relating to prescription drugs used as postexposure 
prophylaxis for the prevention of HIV infection and prior authorizations. 
 
BY repealing and reenacting, without amendments, 
 Article – Health – General 
Section 15–103(a)(1)  
 Annotated Code of Maryland 
 (2019 Replacement Volume and 2021 Supplement) 
 
BY adding to 
 Article – Health – General 
Section 15–103(b)(31) 
 Annotated Code of Maryland 
 (2019 Replacement Volume and 2021 Supplement) 
 
BY adding to 
 Article – Insurance 
Section 15–857 
 Annotated Code of Maryland 
 (2017 Replacement Volume and 2021 Supplement) 
 
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 
That the Laws of Maryland read as follows: 
 
Article – Health – General 
 
15–103. 
 
 (a) (1) The Secretary shall administer the Maryland Medical Assistance 
Program. 
  Ch. 684 	2022 LAWS OF MARYLAND  
 
– 2 – 
 (b) (31) A MANAGED CARE ORGANIZ ATION MAY NOT APPLY A PRIOR 
AUTHORIZATION REQUIR EMENT FOR A PRESCRIP TION DRUG USED AS 
POSTEXPOSURE PROPHYL AXIS FOR THE PREVENT ION OF HIV IF THE 
PRESCRIPTION DRUG IS PRESCRIBED TO A VICTIM OF AN AL LEGED RAPE OR SEXUAL 
OFFENSE FOR USE IN ACCORDANC E WITH CENTERS FOR DISEASE CONTROL AND 
PREVENTION GUIDELINES . 
 
Article – Insurance 
 
15–857. 
 
 (A) (1) THIS SECTION APPLIES TO: 
 
 (I) INSURERS AND NONPROF IT HEALTH SERVICE PL ANS THAT 
PROVIDE COVERAGE FOR PRESCRIPTION DRUGS U NDER INDIVIDUAL, GROUP, OR 
BLANKET HEALTH INSUR ANCE POLICIES OR CON TRACTS THAT ARE ISSU ED OR 
DELIVERED IN THE STATE; AND 
 
 (II) HEALTH MAINTENANCE O RGANIZATIONS THAT PR OVIDE 
COVERAGE FOR PRESCRI PTION DRUGS UNDER IN DIVIDUAL OR GROUP CO NTRACTS 
THAT ARE ISSUED OR DELIVERED IN THE STATE. 
 
 (2) AN INSURER, A NONPROFIT HEALTH S ERVICE PLAN, OR A HEALTH 
MAINTENANCE ORGANIZA TION THAT PROVIDES C OVERAGE FOR PRESCRIP TION 
DRUGS THROUGH A PHAR MACY BENEFITS MANAGE R IS SUBJECT TO THE 
REQUIREMENTS OF THIS SECTION. 
 
 (B) AN ENTITY SUBJECT TO TH IS SECTION MAY NOT A PPLY A PRIOR 
AUTHORIZATION REQUIR EMENT FOR A PRESCRIP TION DRUG USED AS 
POSTEXPOSURE PROPHYL AXIS FOR THE PREVENT ION OF HIV IF THE 
PRESCRIPTION DRUG IS PRESCRIBED TO A VICTIM OF AN AL LEGED RAPE OR SEXUAL 
OFFENSE FOR USE IN ACCORDANCE WITH CENTERS FOR DISEASE CONTROL AND 
PREVENTION GUIDELINES .  
 
 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall apply to all 
policies, contracts, and health benefit plans issued, delivered, or renewed in the State on or 
after January 1, 2023. 
 
 SECTION 3. AND BE IT FURTHER ENACTED, That this Act shall take effect 
January 1, 2023.  
 
Enacted under Article II, § 17(c) of the Maryland Constitution, May 29, 2022.